Works by Grande, Enrique

Results: 124
    1

    Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).

    Published in:
    Clinical & Translational Oncology, 2025, v. 27, n. 7, p. 3223, doi. 10.1007/s12094-024-03827-4
    By:
    • Garcia-Donas, Jesus;
    • Garrigos, Laia;
    • Lainez, Nuria;
    • Santaballa, Ana;
    • Redondo, Andres;
    • Cueva, Juan Fernando;
    • Rubio, Mª Jesus;
    • Prieto, Mario;
    • Lopez-Guerrero, Jose Antonio;
    • Garcia-Casado, Zaida;
    • Barquin, Aranzanzu;
    • Grande, Enrique;
    • Alia, Eva Guerra;
    • Sevillano, Elena;
    • Bover, Isabel;
    • Grazioso, Tatiana P;
    • Sanchez-Escribano, Ramón;
    • Hurtado, Alicia;
    • Navarro, Paloma;
    • Rodriguez-Moreno, Juan Francisco
    Publication type:
    Article
    2

    Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04043-x
    By:
    • Santoni, Matteo;
    • Roviello, Giandomenico;
    • Grande, Enrique;
    • De Giorgi, Ugo;
    • Fiala, Ondrej;
    • Seront, Emmanuel;
    • Molina-Cerrillo, Javier;
    • Pichler, Renate;
    • Myint, Zin W.;
    • Kucharz, Jakub;
    • Kanesvaran, Ravindran;
    • Büttner, Thomas;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Bourlon, Maria T.;
    • Cerbone, Linda;
    • Buchler, Tomas;
    • Pinto, Alvaro;
    • de Liaño, Alfonso Gómez
    Publication type:
    Article
    3

    On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 275, doi. 10.1007/s40487-025-00334-6
    By:
    • Szabados, Bernadett E.;
    • Guerrero-Ramos, Félix;
    • Grande, Enrique;
    • Grivas, Petros;
    • Grünwald, Viktor;
    • Miguel, Marta Carpintero;
    • Hussain, Syed A.;
    • Kulkarni, Girish S.;
    • Wilson, Ana Lisa;
    • Shore, Neal D.;
    • Sridhar, Srikala S.;
    • Hoyt, Mary;
    • Strumeier, Samantha;
    • Sutton, Jennifer;
    • Brinkmann, Julia;
    • Teresi, Rosemary E.;
    • Todenhöfer, Tilman
    Publication type:
    Article
    4

    Estrategia para optimizar la seguridad del paciente en el servicio de dispensación en farmacia comunitaria. Propuesta de listados de verificación.

    Published in:
    Farmacéuticos Comunitarios, 2023, v. 15, n. 2, p. 29, doi. 10.33620/FC.2173-9218.(2023).15
    By:
    • Adsuar-Meseguer, Gonzalo Miguel;
    • Santos-Cruz, Paula;
    • Omar Pérez-Rodríguez, Rafael;
    • Granados-Flores, Jorge;
    • Grande de Ulierte, Enrique;
    • López Alarcón, María Dolores;
    • Abrio-Martín, Cristóbal;
    • Palma-López, Silvia;
    • Luque del Moral, Raúl;
    • Mera Gallego, Inés
    Publication type:
    Article
    5
    6

    Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors.

    Published in:
    Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.676973
    By:
    • Vida Navas, Elena María;
    • Martínez Lorca, Alberto;
    • Sancho Gutiérrez, Aintzane;
    • Sanz Gómez, Lucia;
    • Navarro Martínez, Teresa;
    • Grande Pulido, Enrique;
    • Carrato Mena, Alfredo;
    • Gajate Borau, Pablo
    Publication type:
    Article
    7
    8

    Old and New Insights in the Treatment of Thyroid Carcinoma.

    Published in:
    Journal of Thyroid Research, 2010, p. 1, doi. 10.4061/2010/279468
    By:
    • Gasent Blesa, Joan Manel;
    • Grande Pulido, Enrique;
    • Provencio Pulla, Mariano;
    • Alberola Candel, Vicente;
    • Bautista Laforga Canales, Juan;
    • Grimalt Arrom, Miguel;
    • Martin Rico, Patricia
    Publication type:
    Article
    9
    10

    Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 305, doi. 10.1016/j.clgc.2023.11.013
    By:
    • Marques Monteiro, Fernando Sabino;
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Büttner, Thomas;
    • Grande, Enrique;
    • Bourlon, Maria Teresa;
    • Molina-Cerrillo, Javier;
    • Pichler, Renate;
    • Buchler, Tomas;
    • Seront, Emmanuel;
    • Ansari, Jawaher;
    • Bamias, Aristotelis;
    • Bhuva, Dipen;
    • Vau, Nuno;
    • Porta, Camillo;
    • Fay, Andre Poisl;
    • Santoni, Matteo
    Publication type:
    Article
    11

    Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).

    Published in:
    Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. e309, doi. 10.1016/j.clgc.2023.03.006
    By:
    • Santoni, Matteao;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Salfi, Alessia;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    12
    13
    14

    Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 285, doi. 10.1016/j.clgc.2022.02.003
    By:
    • Santoni, Matteo;
    • Aurilio, Gaetano;
    • Massari, Francesco;
    • Grande, Enrique;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • Giorgi, Ugo De;
    • Incorvaia, Lorena;
    • Martignetti, Angelo;
    • Molina-Cerrillo, Javier;
    • Zabalza, Ignacio Ortego;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Battelli, Nicola;
    • Porta, Camillo
    Publication type:
    Article
    15
    16

    Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 905, doi. 10.1007/s11523-024-01099-0
    By:
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Basso, Umberto;
    • Giannatempo, Patrizia;
    • Grande, Enrique;
    • Buti, Sebastiano;
    • Myint, Zin W.;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Grillone, Francesco;
    • Ürün, Yüksel;
    • Calabrò, Fabio;
    • Bourlon, Maria T.;
    • Galli, Luca;
    • Kanesvaran, Ravindran;
    • Roviello, Giandomenico;
    • Kucharz, Jakub;
    • Rizzo, Mimma;
    • Park, Se Hoon;
    • Cerbone, Linda
    Publication type:
    Article
    17

    Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1).

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 893, doi. 10.1007/s11523-024-01096-3
    By:
    • Santini, Daniele;
    • Li, Haoran;
    • Roviello, Giandomenico;
    • Park, Se Hoon;
    • Grande, Enrique;
    • Kucharz, Jakub;
    • Basso, Umberto;
    • Fiala, Ondrej;
    • Monteiro, Fernando Sabino Marques;
    • Poprach, Alexandr;
    • Buti, Sebastiano;
    • Molina-Cerrillo, Javier;
    • Catalano, Martina;
    • Buchler, Tomas;
    • Seront, Emmanuel;
    • Ansari, Jawaher;
    • Myint, Zin W.;
    • Ghosn, Marwan;
    • Calabrò, Fabio;
    • Kopp, Ray Manneh
    Publication type:
    Article
    18

    Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

    Published in:
    Targeted Oncology, 2024, v. 19, n. 4, p. 587, doi. 10.1007/s11523-024-01065-w
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Bamias, Aristotelis;
    • Massari, Francesco;
    • Pichler, Renate;
    • Maruzzo, Marco;
    • Grande, Enrique;
    • De Giorgi, Ugo;
    • Molina-Cerrillo, Javier;
    • Seront, Emmanuel;
    • Calabrò, Fabio;
    • Myint, Zin W.;
    • Facchini, Gaetano;
    • Kopp, Ray Manneh;
    • Berardi, Rossana;
    • Kucharz, Jakub;
    • Vitale, Maria Giuseppa;
    • Pinto, Alvaro;
    • Formisano, Luigi;
    • Büttner, Thomas
    Publication type:
    Article
    19

    Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Rizzo, Mimma;
    • Galli, Luca;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah
    Publication type:
    Article
    20

    Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.

    Published in:
    2022
    By:
    • Santoni, Matteo;
    • Molina-Cerrillo, Javier;
    • Myint, Zin W.;
    • Massari, Francesco;
    • Buchler, Tomas;
    • Buti, Sebastiano;
    • Matrana, Marc R.;
    • De Giorgi, Ugo;
    • Rizzo, Mimma;
    • Zabalza, Ignacio Ortego;
    • Galli, Luca;
    • Zucali, Paolo Andrea;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Bassanelli, Maria;
    • Mammone, Giulia;
    • Salfi, Alessia;
    • Isella, Luca;
    • Mollica, Veronica;
    • Grande, Enrique
    Publication type:
    journal article
    21

    Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

    Published in:
    Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Grande, Enrique;
    • Procopio, Giuseppe;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • De Giorgi, Ugo;
    • Basso, Umberto;
    • Milella, Michele;
    • Iacovelli, Roberto;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Buti, Sebastiano;
    • Caffo, Orazio;
    • Fornarini, Giuseppe;
    • Carrozza, Francesco;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Farag, Fady;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    22
    23

    The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).

    Published in:
    2019
    By:
    • Font, Albert;
    • Luque, Raquel;
    • Villa, José Carlos;
    • Domenech, Montse;
    • Vázquez, Sergio;
    • Gallardo, Enrique;
    • Virizuela, Juan Antonio;
    • Beato, Carmen;
    • Morales-Barrera, Rafael;
    • Gelabert, Antoni;
    • Maciá, Sonia;
    • Puente, Javier;
    • Rubio, Gustavo;
    • Maldonado, Xavier;
    • Perez-Valderrama, Begoña;
    • Pinto, Alvaro;
    • Fernández Calvo, Ovidio;
    • Grande, Enrique;
    • Garde-Noguera, Javier;
    • Fernández-Parra, Eva
    Publication type:
    journal article
    24
    25
    26

    Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1512-6
    By:
    • Capdevila, Jaume;
    • Sevilla, Isabel;
    • Alonso, Vicente;
    • Aparicio, Luís Antón;
    • Fonseca, Paula Jiménez;
    • Grande, Enrique;
    • Reina, Juan José;
    • Manzano, José Luís;
    • Alonso, Juan Domingo;
    • Lájara;
    • Barriuso, Jorge;
    • Castellano, Daniel;
    • Medina, Javier;
    • López, Carlos;
    • Segura, Ángel;
    • Carrera, Sergio;
    • Crespo, Guillermo;
    • Fuster, José;
    • Munarriz, Javier;
    • Alfonso, Pilar García
    Publication type:
    Article
    27

    Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 495, doi. 10.1186/s12885-015-1512-6
    By:
    • Capdevila, Jaume;
    • Sevilla, Isabel;
    • Alonso, Vicente;
    • Aparicio, Luís Antón;
    • Fonseca, Paula Jiménez;
    • Grande, Enrique;
    • Reina, Juan José;
    • Manzano, José Luís;
    • Alonso Lájara, Juan Domingo;
    • Barriuso, Jorge;
    • Castellano, Daniel;
    • Medina, Javier;
    • López, Carlos;
    • Segura, Ángel;
    • Carrera, Sergio;
    • Crespo, Guillermo;
    • Fuster, José;
    • Munarriz, Javier;
    • Alfonso, Pilar García
    Publication type:
    Article
    28

    Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.

    Published in:
    2015
    By:
    • Capdevila, Jaume;
    • Sevilla, Isabel;
    • Alonso, Vicente;
    • Antón Aparicio, Luís;
    • Jiménez Fonseca, Paula;
    • Grande, Enrique;
    • Reina, Juan José;
    • Manzano, José Luís;
    • Alonso Lájara, Juan Domingo;
    • Barriuso, Jorge;
    • Castellano, Daniel;
    • Medina, Javier;
    • López, Carlos;
    • Segura, Angel;
    • Carrera, Sergio;
    • Crespo, Guillermo;
    • Fuster, José;
    • Munarriz, Javier;
    • García Alfonso, Pilar;
    • Segura, Ángel
    Publication type:
    journal article
    29
    30
    31

    Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04019-x
    By:
    • Porta, Camillo;
    • Massari, Francesco;
    • Taha, Tarek;
    • Grande, Enrique;
    • Bourlon, Maria T.;
    • Kanesvaran, Ravindran;
    • Basso, Umberto;
    • Molina-Cerrillo, Javier;
    • Alonso-Gordoa, Teresa;
    • Myint, Zin W.;
    • Fornarini, Giuseppe;
    • Buttner, Thomas;
    • Park, Se Hoon;
    • Ürün, Yüksel;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Rescigno, Pasquale;
    • Buchler, Tomas;
    • Studentova, Hana;
    • Melichar, Bohuslav
    Publication type:
    Article
    32

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
    By:
    • Massari, Francesco;
    • Santoni, Matteo;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Tapia, Jose Carlos;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Gandur, Nathalia;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique
    Publication type:
    Article
    33

    Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3665, doi. 10.1007/s00262-023-03518-z
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Massari, Francesco;
    • Palacios, Georgia Anguera;
    • Dionese, Michele;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Quiroga, María Natalia Gandur;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique;
    • Mammone, Giulia
    Publication type:
    Article
    34

    Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
    By:
    • Santoni, Matteo;
    • Myint, Zin W.;
    • Büttner, Thomas;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Küronya, Zsófia;
    • Tural, Deniz;
    • Pichler, Renate;
    • Grande, Enrique;
    • Crabb, Simon J.;
    • Kemp, Robert;
    • Massari, Francesco;
    • Scagliarini, Sarah;
    • Iacovelli, Roberto;
    • Vau, Nuno;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    35

    Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1365, doi. 10.1007/s00262-022-03349-4
    By:
    • Santoni, Matteo;
    • Rizzo, Alessandro;
    • Kucharz, Jakub;
    • Mollica, Veronica;
    • Rosellini, Matteo;
    • Marchetti, Andrea;
    • Tassinari, Elisa;
    • Monteiro, Fernando Sabino Marques;
    • Soares, Andrey;
    • Molina-Cerrillo, Javier;
    • Grande, Enrique;
    • Battelli, Nicola;
    • Massari, Francesco
    Publication type:
    Article
    36

    Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.

    Published in:
    Oncology & Therapy, 2020, v. 8, n. 2, p. 171, doi. 10.1007/s40487-020-00124-2
    By:
    • de las Heras, Begoña;
    • Saini, Kamal S.;
    • Boyle, Frances;
    • Ades, Felipe;
    • de Azambuja, Evandro;
    • Bozovic-Spasojevic, Ivana;
    • Romano, Marco;
    • Capelan, Marta;
    • Prasad, Rajeev;
    • Pattu, Pugazhenthi;
    • Massard, Christophe;
    • Portera, Chia;
    • Saini, Monika Lamba;
    • Singh, Brajendra Prasad;
    • Venkitaraman, Ramachandran;
    • McNally, Richard;
    • Leone, Manuela;
    • Grande, Enrique;
    • Gupta, Sudeep
    Publication type:
    Article
    37
    38
    39
    40

    Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.

    Published in:
    Clinical & Translational Oncology, 2025, v. 27, n. 5, p. 2241, doi. 10.1007/s12094-024-03652-9
    By:
    • Osorio, Lucia;
    • Grazioso, Tatiana P.;
    • de Velasco, Guillermo;
    • Etxaniz, Olatz;
    • Pérez-Gracia, Jose Luis;
    • Pinto, Álvaro;
    • Durán, Ignacio;
    • Grande, Enrique;
    • Garcia, Pablo Borrega;
    • Lázaro, Martín;
    • Rodriguez, Laura;
    • Villalobos, Maria Laura;
    • García, Lourdes;
    • Cuellar, Andrés;
    • Solís-Hernández, María Pilar;
    • Pernaut, Cristina;
    • Rodríguez-Moreno, Juan Francisco;
    • Rodriguez-Antona, Cristina;
    • García-Donas, Jesús
    Publication type:
    Article
    41

    SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

    Published in:
    Clinical & Translational Oncology, 2023, v. 25, n. 9, p. 2692, doi. 10.1007/s12094-023-03205-6
    By:
    • Castillón, Jaume Capdevila;
    • Gordoa, Teresa Alonso;
    • Bayonas, Alberto Carmona;
    • Carretero, Ana Custodio;
    • García-Carbonero, Rocío;
    • Pulido, Enrique Grande;
    • Fonseca, Paula Jiménez;
    • Lete, Angela Lamarca;
    • Huerta, Angel Segura;
    • Plazas, Javier Gallego
    Publication type:
    Article
    42

    Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 8, p. 1301, doi. 10.1002/cncr.31909
    By:
    • Vink, Peter;
    • Delgado Mingorance, Ignacio;
    • Maximiano Alonso, Constanza;
    • Rubio‐Viqueira, Belen;
    • Jung, Kyung Hae;
    • Rodriguez Moreno, Juan Francisco;
    • Grande, Enrique;
    • Marrupe Gonzalez, David;
    • Lowndes, Sarah;
    • Puente, Javier;
    • Kristeleit, Hartmut;
    • Farrugia, David;
    • McNeil, Shelly A.;
    • Campora, Laura;
    • Di Paolo, Emmanuel;
    • El Idrissi, Mohamed;
    • Godeaux, Olivier;
    • López‐Fauqued, Marta;
    • Salaun, Bruno;
    • Heineman, Thomas C.
    Publication type:
    Article
    43

    Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

    Published in:
    2019
    By:
    • Vink, Peter;
    • Delgado Mingorance, Ignacio;
    • Maximiano Alonso, Constanza;
    • Rubio-Viqueira, Belen;
    • Jung, Kyung Hae;
    • Rodriguez Moreno, Juan Francisco;
    • Grande, Enrique;
    • Marrupe Gonzalez, David;
    • Lowndes, Sarah;
    • Puente, Javier;
    • Kristeleit, Hartmut;
    • Farrugia, David;
    • McNeil, Shelly A;
    • Campora, Laura;
    • Di Paolo, Emmanuel;
    • El Idrissi, Mohamed;
    • Godeaux, Olivier;
    • López-Fauqued, Marta;
    • Salaun, Bruno;
    • Heineman, Thomas C
    Publication type:
    journal article
    44
    45
    46

    Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5413, doi. 10.1007/s10238-023-01235-6
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Takeshita, Hideki;
    • Tapia, Jose Carlos;
    • Dionese, Michele;
    • Pichler, Renate;
    • Rizzo, Mimma;
    • Lam, Elaine T.;
    • Grande, Enrique;
    • Kemp, Robert;
    • Molina-Cerrillo, Javier;
    • Calabrò, Fabio;
    • Tural, Deniz;
    • Küronya, Zsófia;
    • Kucharz, Jakub;
    • Fiala, Ondrej;
    • Seront, Emmanuel;
    • Kopp, Ray Manneh;
    • Abahssain, Halima;
    • Kopecky, Jindrich
    Publication type:
    Article
    47
    48

    Sunitinib-induced asthenia.

    Published in:
    Cancer Biology & Therapy, 2011, v. 12, n. 9, p. 765, doi. 10.4161/cbt.12.9.18138
    By:
    • Aparicio, Luis M. Antón;
    • Pulido, Enrique Grande;
    • Gallego, Guadalupe Aparicio
    Publication type:
    Article
    49

    Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).

    Published in:
    European Journal of Endocrinology, 2017, v. 177, n. 5, p. 309, doi. 10.1530/EJE-17-0243
    By:
    • Capdevila, Jaume;
    • Manuel Trigo, José;
    • Aller, Javier;
    • Luís Manzano, José;
    • García Adrián, Silvia;
    • Llopis, Carles Zafón;
    • Reig, Òscar;
    • Bohn, Uriel;
    • Ramón y Cajal, Teresa;
    • Duran-Poveda, Manuel;
    • González Astorga, Beatriz;
    • López-Alfonso, Ana;
    • Medina Martínez, Javier;
    • Porras, Ignacio;
    • Jose Reina, Juan;
    • Palacios, Nuria;
    • Grande, Enrique;
    • Cillán, Elena;
    • Matos, Ignacio;
    • Jose Grau, Juan
    Publication type:
    Article
    50

    Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).

    Published in:
    European Journal of Endocrinology, 2017, v. 177, n. 4, p. 309, doi. 10.1530/EJE-17-0243
    By:
    • Capdevila, Jaume;
    • Trigo, José Manuel;
    • Aller, Javier;
    • Manzano, José Luís;
    • Adrián, Silvia García;
    • Llopis, Carles Zafón;
    • Reig, Òscar;
    • Bohn, Uriel;
    • Ramón y Cajal, Teresa;
    • Duran-Poveda, Manuel;
    • González Astorga, Beatriz;
    • López-Alfonso, Ana;
    • Martínez, Javier Medina;
    • Porras, Ignacio;
    • Reina, Juan Jose;
    • Palacios, Nuria;
    • Grande, Enrique;
    • Cillán, Elena;
    • Matos, Ignacio;
    • Grau, Juan Jose
    Publication type:
    Article